Effect of atorvastatin on dendritic cells of tubulointerstitium in diabetic rats

Yafang Tu1, Ruhan Jia, Guohua Ding

  • 1Nephrology Department, Renmin Hospital of Wuhan University, Wuhan, China.

BMB Reports
|April 2, 2010
PubMed

Insights

Dendritic cells (DCs) drive kidney damage in diabetes via P-selectin. Atorvastatin reduces this damage by inhibiting P-selectin and DC migration, offering a potential therapeutic strategy for diabetic kidney disease.

Area of Science:

  • Nephrology
  • Immunology
  • Pharmacology

Background:

  • Diabetic kidney disease (DKD) involves significant inflammatory processes.
  • The role of dendritic cells (DCs) in DKD-related tubulointerstitial damage requires further elucidation.
  • P-selectin is implicated in inflammatory cell trafficking and may play a role in DKD pathogenesis.

Purpose of the Study:

  • To investigate the role of dendritic cells (DCs) in mediating tubulointerstitial damage in a rat model of diabetes.
  • To determine if P-selectin expression is involved in DC accumulation and subsequent renal injury.
  • To evaluate the potential renoprotective effects of atorvastatin by targeting P-selectin and DC migration.

Main Methods:

  • Establishment of a streptozotocin (STZ)-induced diabetic rat model.
  • Assessment of DC accumulation and P-selectin expression in renal tissues.
  • Correlation analysis between DC markers, P-selectin levels, and the extent of tubulointerstitial injury.
  • Administration of atorvastatin to assess its inhibitory effects.

Main Results:

  • Significant accumulation of dendritic cells (DCs) was observed in the kidneys of diabetic rats.
  • P-selectin expression was elevated in diabetic kidneys and correlated with DC accumulation.
  • Both DC accumulation and P-selectin expression were closely associated with the severity of renal tubulointerstitial injury.
  • Atorvastatin treatment markedly attenuated DC accumulation, P-selectin expression, and tubulointerstitial damage.

Conclusions:

  • Dendritic cells (DCs) play a crucial role in mediating tubulointerstitial damage in diabetic kidney disease.
  • P-selectin-mediated DC migration contributes to renal injury in this model.
  • Atorvastatin demonstrates renoprotective effects by inhibiting P-selectin expression and DC migration, suggesting a therapeutic potential for DKD.

Related Concept Videos